期刊文献+

氯吡格雷类似物的合成及其抗血小板聚集活性 被引量:6

Synthesis of Clopidogrel Analogues and Their Anti-platelet Aggregation Activities
下载PDF
导出
摘要 α-溴代邻氯苯乙酸经酯化反应后再与4,5,6,7-四氢噻吩并[3,2-c]吡啶发生取代反应合成氯吡格雷类似物(4b^4e);2-(2-氯苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5-基)乙酸(4a)经酯化反应合成4f^4k;4f与AgNO3反应制得4l;4a经酰胺化制得另外两个氯吡格雷类似物(5c和5m)。4和5的其结构经1HNMR,IR和MS表征。初步生物活性测试结果表明:4和5均有一定的抗血小板聚集作用,其中4g和4b尤其突出,对大鼠血小板聚集的抑制百分率分别为46.1%和38.2%。 Clopidogrel analogues(4b^4e) were synthesized by esterification of α-bromo-o-chlorophenylacetic acid with ROH,and then substitution reaction with 4,5,6,7-tetrahydro-thienopyridyl.4f^4k were synthesized by esterification of α-(4,5,6,7-tetrahydro-thieno-5-pyridyl)-2-chlorophenylacetic acid(4a) with ROH.4f reacted with AgNO3 to give 4l.Another clopidogrel analogues(5c,5m) were prepared by amidation of 4a with RNH2.The structures of 4 and 5 were characterized by 1H NMR,IR and MS.The biological actiyity tests showed that all of 4 and 5 exhibited significant anti-platelet aggregation.For anti-platelet aggregation of rats,the inhibition rate of 4g and 4b were 46.1% and 38.2%,respectively.
出处 《合成化学》 CAS CSCD 北大核心 2010年第5期586-590,共5页 Chinese Journal of Synthetic Chemistry
基金 天津市自然科学基金重点项目(10JCZDJC21900) "重大新药创制"科技重大专项项目(2009ZX09103-078) 天津市科技计划项目(09ZCKFSH01300)
关键词 氯吡格雷 ADP受体拮抗剂 噻吩并吡啶 合成 抗血小板聚集活性 Clopidogrel ADP receptor antagonist thienopyridine synthesis anti-platelet aggregation activity
  • 相关文献

参考文献7

  • 1刘登科,刘颖,刘默,等.含噻吩并吡啶的哌嗪类衍生物、其制备方法和用途[P].CN101284838A,2008.
  • 2Erie L, Hiralal N K. 2-(2-nitrovinyl)thiophene reduction and synthesis of thieno[3,2-c] pyridine derivatives [P]. EP 0 342 118 A1,1989.
  • 3Bouisset M, Radisson J. Process for the preparation of α-bromo-phenylacetic acids[ P]. US 5 035 156,1991.
  • 4Aubert D, Ferrand C, Maffrand J P. Thieno[3,2-c] pyridine derivatives and their therapeutic application [P]. US 4 529 596,1985.
  • 5Bipin P, Bhushan L V, Bhushan L B, et al. process for preparing elopidogrel [ P ]. WO 02/059 128 A2, 2002.
  • 6Silva R A. Preparation of (S)-elopidogrel and related compounds[ P]. WO 2 004/094 374 A2, 2004.
  • 7Savi P, Herbert J M, Pflieger A M, et al. Importance of hepatic metabolism in the antiaggregafine activity of the thienopyridine clopidogrel [ J ]. Biochemical Pharmacology, 1992,44 (3) :527 - 532.

共引文献2

同被引文献60

  • 1陈冬梅,陈凯,汪海.吗啉环和哌嗪环类衍生物的抗血栓作用及其分子机制[J].药学学报,2003,38(9):641-645. 被引量:10
  • 2Gergely Feher,Andrea Feher,Gabriella Pusch,Katalin Koltai,Antal Tibold,Beata Gasztonyi,Elod Papp,Laszlo Szapary,Gabor Kesmarky,Kalman Toth.Clinical importance of aspirin and clopidogrel resistance[J].World Journal of Cardiology,2010,2(7):171-186. 被引量:36
  • 3WeiYiCHEN JunLU.Efficient Esterification of Ferrocenecarboxylic Acid in Ionic Liquids[J].Chinese Chemical Letters,2004,15(10):1146-1148. 被引量:6
  • 4王凤霞,张卓勇,王亚敏,范国强.近红外光谱技术在医药领域应用的新进展[J].首都师范大学学报(自然科学版),2005,26(3):53-59. 被引量:15
  • 5唐培垄.精细有机合成化学及工艺学[M].天津:天津大学出版社,2002.
  • 6Panak E, Maffrand J P, Picard-Fraire C, et al. Thclo- pidine:A promise for the prevention and treatment of thrombosis and its complications [ J ]. Haemostasis, 1983,13(1) :1 -54.
  • 7Coukell A J, Markham A. Clopidogrel [ J ]. Drugs, 1997,54(5 ) :745 - 750.
  • 8Hashlmoto M, Sugidachi A, Isobe T, et al. The influ- ence of P2Yn receptor deficiency o the platelet inhibi-tory activities of prasugrel in a mouse model: Evidence for specific inhibition of P2YI2 receptors by prasugrel [ J ]. Biochemical Pharmacology, 2007,74 (7) : 1003 - 1009.
  • 9刘登科,王平保,赵专友,等.噻吩并吡啶取代的乙酰肼衍生物[P].中国,200510016205.X,2005.
  • 10刘登科,刘颖,岳南,等.一类含腈基的噻吩并吡啶酯类衍生物、其制备方法和用途[P].CN,201010171152.X,2010.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部